Keywords: 16; 23; 38; ADP; adenosine diphosphate; APT; antiplatelet therapy; BOCLA-Plan; BOchum CLopidogrel and Aspirin Plan; CABG; coronary artery bypass grafting; CI; confidence interval; CYP; cytochrome P450; dAPT; dual antiplatelet therapy; HR; hazard ratio; hR
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: bare-metal stent(s); drug-eluting stent(s); stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); FDA; Food and D
Keywords: 7,8-DHF; 7,8-dihydroxyflavone; Aβ; amyloid beta; AchE; acetylcholine-esterase; ABCA1; ATP-binding cassette transporter 1; APP; amyloid precursor protein; Akt; protein kinase B; ApoE; apolipoprotein E; AAV/Aβ; adeno-associated viral vector carrying Aβ c
Keywords: 8-Br-cGMP; 8-Bromoguanosine 3â²,5â²-cyclic monophosphate; cGMP; guanosine 3â²,5â²-cyclic monophosphate; DAPT; N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester; EIA; enzyme immunoassay; GSNO; S-Nitrosoglutathione; IOSE; immortalize
To EncourAGE Individualized Dual Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation
Keywords: age; DAPT; drug-eluting stent(s); elderly; individualized therapy;
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
Keywords: bioresorbable scaffold; thrombosis; BRS; bioresorbable stent(s); BVS; Bioresorbable Vascular Scaffold; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MLD; minimum lumen diameter; QCA; quantitative coronary angiography; RVD; reference vessel
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT
Keywords: ACS; Acute coronary syndrome; CP; Clopidogrel period; DAPT; Dual antiplatelet therapy; DES; Drug-eluting stent; HBR; High bleeding risk; MI; Myocardial infarction; NACCE; Net adverse clinical and cerebral events; PCI; Percutaneous coronary intervention; T
PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention
Keywords: ABCB1; ATP-binding cassette, sub-family B, member 1; ACEI; angiotensinconverting enzyme inhibitor; ADP; adenosine diphosphate; ARB; angiotensin receptor blocker; CCB; calcium channel blockers; CHD; Coronary Heart Disease; CLP; clopidogrel; CLPM; clopidogr
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Keywords: cardiovascular outcomes; coronary disease; platelet; CABG; coronary artery bypass graft; CI; confidence interval; CV; cardiovascular; DAPT; dual antiplatelet therapy; HR; hazard ratio; ICH; intracranial hemorrhage; KM; Kaplan-Meier; MACE; major adverse ca
Notch signaling pathway dampens tumor-infiltrating CD8+ T cells activity in patients with colorectal carcinoma
Keywords: CCK-8; cell counting kit-8; CTLA-4; cytotoxic T-lymphocyte associated protein-4; DAPT; N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenyl glycinet-butyl ester; FBS; fetal bovine serum; GM-CSF; granulocyte-macrophage colony stimulating factor; IFN-γ; interf
Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina
Keywords: chronic refractory angina; coronary sinus reducer; optimal medical therapy; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CCS; Canadian Cardiovascular Society; CS; coronary sinus; DAPT; dual antiplatelet therapy; IQR; interquartile
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Keywords: Antithrombotic; Anticoagulation; Antiplatelet; Surgery; Antitrombótico; Anticoagulación; Antiagregación; CirugÃa; AF; atrial fibrillation; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; DOAC; direct oral anticoagulant; PCI; percutaneous cor
Critical Appraisal of the 2018 ACC Scientific Sessions Late-Breaking Trials From a Statistician's Perspective
Keywords: clinical trials; conference presentations; critical appraisal; CHD; coronary heart disease; DAPT; dual antiplatelet therapy; MACE; major adverse cardiovascular events; MI; myocardial infarction; NSTEMI; non-ST-segment elevation myocardial infarction; oG
The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation
Keywords: Transcatheter aortic valve implantation; Bleeding complications; Platelet reactivity assessment; Implantation de valve aortique transcathéter; Complications hémorragiques; Ãvaluation de la réactivité plaquettaire; ARU; aspirin reaction units; AUC; ar
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the Fr
Keywords: Antiplatelet therapy; Surgery; Haemorrhage; Thrombosis; Local anaesthesia; Agent antiplaquettaire; Chirurgie; Hémorragie; Thrombose; Anesthésie loco-régionale; ADP; adenosine diphosphate; CABG; coronary artery bypass graft; DAPT; dual antiplatelet ther
The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist
Keywords: ACS; acute coronary syndrome; ACT; activated clotting time; ADP; adenosine diphosphate; AHA/ACC; American Heart Association American/College of Cardiology; APTT; activated partial thromboplastin time; AVM; arteriovenous malformation; BID; twice daily; CAB
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - “Real World” Experience
Keywords: ACS; acute coronary syndrome; AF; atrial fibrillation; BARC; bleeding academic research consortium; CAD; coronary artery disease; CHA2DS2-VASc; congestive heart failure, hypertension, ageâ¯â¥â¯75p years (doubled), diabetes mellitus, prior stroke or TIA
CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han
Keywords: CAD; coronary artery disease; ACS; acute coronary syndrome; DAPT; dual antiplatelet therapy; PCI; percutaneous coronary intervention; SNPs; single nucleotide polymorphisms; LD; loading dose; MD; maintain dose; PRI; platelet reaction index; HTPR; high on-t
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
Keywords: ACC; American College of Cardiology; ACS; Acute Coronary Syndrome; ACT; Activated Clotting Time; AF; Atrial Fibrillation; AHA; American Heart Association; aPCC; Activated Prothrombin Complex Concentrate; aPTT; Activated Partial Thromboplastin Time; CAD; C
Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes
Keywords: BVS; bioresorbable vascular scaffolds; DAPT; double antiplatelet therapy; DES; drug-eluting stent; IVUS; intravascular ultrasound; MDCT; multiple detector computed tomography; LAD; left anterior descending artery; MI; myocardial infarction; OCT; optical c
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
Keywords: ACE-I; angiotensin-converting-enzyme inhibitors; ACS; acute coronary syndrome; ARB; angiotensin receptor blocker; CABG; coronary artery bypass grafting; CI; confidence interval; CHF; congestive heart failure; DAPT; dual antiplatelet therapy; DES; drug elu
Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician
Keywords: ACC; American College of Cardiology; ACS; Acute coronary syndromes; AHA; American Heart Association; BMI; Body mass index; BMS; Bare metal stents; CAD; Coronary artery disease; CI; Confidence interval; CKD; Chronic kidney disease; CV; Cardiovascular; DAPT
Effect of dioscin on promoting liver regeneration via activating Notch1/Jagged1 signal pathway
Keywords: Dioscin; Hepatocyte proliferation; γ-secretase; Liver regeneration; Notch1/Jagged1 signal pathway; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BrdU; 5-bromo-2-deoxy-uridine; CDK2; cyclin D-cyclin dependent kinase 2; CDK4; cyclin D-cyc
Simvastatin alters M1/M2 polarization of murine BV2 microglia via Notch signaling
Keywords: Simvastatin; Notch signaling pathway; Microglia; M1/M2 polarization; LPS; Jagged-1/FC protein; DAPT;
Notch signaling is impaired during inflammation in a Lunatic Fringe-dependent manner
Keywords: AJ; adherence junction; APC; Allophycocyanin; BBB; blood-brain barrier; BECs; brain endothelial cells; CNS; central nervous system; DAPT; N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester; DLL1, -3 and -4; Delta-like family ligand 1, -
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
Keywords: ACS; acute coronary syndrome; ACCOAST trial; Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time of Diagnosis in Patients with Non-ST Elevation Myocardial Infarction trial; ACUITY; acute catheterization
Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial
Keywords: antiplatelet drugs; coronary disease; coronary artery bypass graft; BITA; bilateral internal thoracic arteries; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CASCADE; Clopidogrel After Surgery for Coronary Artery Disease; CCTA; coro
Recent progress on the sensitive detection of cardiovascular disease markers by electrochemical-based biosensors
Keywords: [Fe(CN)6]3â/4â; potassiumferricyanide/ferrocyanide; 4-ATP; 4-aminothiophenol; AChE; acetylcholine esterase; AdSSWV; adsorptive stripping square-wave voltammetry; Affibodys; combinatorial non-immunoglobulin protein; AG; anodized graphene; Ag; silver; A
Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia
Keywords: ACS; acute coronary syndrome; BARC; bleeding academic research consortium; BMS; bare metal stent; DAPT; dual antiplatelet therapy; DES; drug eluting stent; GP IIb-IIIa; glycoprotein IIb-IIIa receptors; ICU; intensive cardiac unit; LVEF; left ventricle eje
Thrombocytopenia associated with TAVI-The summary of possible causes
Keywords: AS; aortic valve stenosis; BCMD; blood contacting medical devices; DAPT; dual antiplatelet therapy; DIC; disseminated intravascular coagulation; ES; Edwards Sapien; FS; Freedom Solo; F1+2; prothrombin fragments 1+2; GP; platelet glycoprotein; HIT; heparin
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
Keywords: ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; DAPT; Dual antiplatelet therapy; HRPR; High-residual on treatment platelet reactivity; ASA; Acetylsalycilic acid; DES; Drug-eluting stents; CAD; Coronary artery disease; ADP; Adenosine
Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study
Keywords: DAPT; dual antiplatelet therapy; DES; drug-eluting stent; EES; everolimus eluting stent; ISA; incomplete stent apposition; LAISA; late acquired incomplete stent apposition; OCT; optical coherence tomography; PES; paclitaxel eluting stent; PCI; percutaneou
Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent
Keywords: Stent; Endothelialization; Healing; COBRA PzF stent; Polyzene-F; Stent; Endothalization; Guérison; COBRA PzF stent; Polyzène-F; BMS; bare-metal stent; CABG; coronary artery bypass graft; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; NSTEMI;
Systematic time-dependent visualization and quantitation of the neurogenic rate in brain organoids
Keywords: Quantitative image processing; Tbr2; Corticogenesis; Microfabrication; Neural ball; DAPT;
Original ArticleSafety and Efficacy of a 600-mg Loading Dose of Clopidogrel 24 Hours Before Pipeline Embolization Device Treatment
Keywords: Aneurysm; Bolus; Clopidogrel; Loading dose; Pipeline Embolization Device; CI; Confidence interval; DAPT; Dual antiplatelet therapy; mRS; Modified Rankin Scale; OR; Odds ratio; PCI; Percutaneous coronary intervention; PED; Pipeline Embolization Device; PRU
Coronary Artery Bypass Graft Surgery Using the Radial Artery, Right Internal Thoracic Artery, or Saphenous Vein as the Second Conduit
Keywords: BIMC; Beth Israel Medical Center; BITA; bilateral internal thoracic artery; CABG; coronary artery bypass graft surgery; CI; confidence interval; DAPT; dual antiplatelet therapy; HR; hazard ratio; LAD; left anterior descending artery; LITA; left internal t
Intrinsic lens potential of neural retina inhibited by Notch signaling as the cause of lens transdifferentiation
Keywords: Neural retina; Lens transdifferentiation; Notch signaling; DAPT;
Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction
Keywords: AMI; acute myocardial infarction; DAMPs; damage-associated molecular patterns; DAPT; dual anti-platelet therapy; FSL-1; fibroblast-stimulating lipopeptide-1; I/R; ischaemia/reperfusion; LPS; lipopolysaccharide; MFI; mean fluorescent intensity; PAMPs; path
Clinical ResearchPercutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomesFermeture percutanée de l'auricule gauche suivie d'une monothérapie antiaggrégante plaquettaire : devenir à court et
Keywords: Left atrial appendage; Percutaneous closure; Stroke; Atrial fibrillation; Auricule gauche; Fermeture percutanée; Accident vasculaire cerebral; Fibrillation atriale; ACP; AMPLATZER⢠cardiac plug; AF; Atrial fibrillation; CT; Computed tomography; DAPT; D
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry
Keywords: ACC/AHA; American College of Cardiology/American Heart Association; DAPT; dual antiplatelet therapy; DES; drug eluting stents; LM/pLAD; left main/proximal left anterior descending artery; MACE; major adverse cardiac events; MI; myocardial infarction; PARI
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent
Keywords: drug-eluting stent; percutaneous coronary intervention; Resolute zotarolimus-eluting stent; stent thrombosis; ARC; Academic Research Consortium; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarction; R-ZES; Resolute zotaro
“Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)
Keywords: OCT; optical coherence tomography; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; LMWH; low molecular weight heparin; NSTEMI; non ST-segment elevation myocardial infarction; PROTECT-OCT; Prospective Registry of Cancer Patients with Coronary Ste
Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve
Keywords: aortic stenosis; aspirin; bleeding; clopidogrel; stroke; transcatheter aortic valve replacement; CI; confidence interval; DAPT; dual antiplatelet therapy; MI; myocardial infarction; OR; odds ratio; SAPT; single-antiplatelet therapy; TAVR; transcatheter a
Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease
Keywords: bioresorbable scaffold; coronary artery disease; percutaneous coronary intervention; BRS; bioresorbable scaffold(s); DAPT; dual-antiplatelet therapy; DES; drug-eluting metal stent(s); eBRS; everolimus-eluting bioresorbable scaffold(s); MACE; major adverse
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ
Keywords: Amyloid-β; γ-secretase; DAPT; Duolink; Neurons; Oligomers;
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent
Keywords: drug-eluting stent(s); drug-filled stent(s); percutaneous coronary intervention; polymer-free stent; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); DFS; drug-filled stent(s); IVUS; intravascular ultrasound; MI; myoc
Dual Antiplatelet Therapy for 6 Versus 18Â Months After Biodegradable Polymer Drug-Eluting Stent Implantation
Keywords: biodegradable polymer; drug-eluting stent(s); dual antiplatelet therapy; net adverse clinical and cerebrovascular event(s); stent thrombosis; BARC; Bleeding Academic Research Consortium; CI; confidential interval; DAPT; dual antiplatelet therapy; DES; dru
The State of the Absorb Bioresorbable Scaffold
Keywords: bioresorbable scaffold; polymer poly-L-lactic acid; scaffold thrombosis; BRS; bioresorbable scaffold; CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); IVUS; intravascular ultrasound; OCT;
Original ArticleEssential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer
Keywords: Tamoxifen resistance; Breast cancer; Metastasis; Notch4; STAT3; AP-1; Activator protein-1; CSCs; cancer stem cells; DAPT; N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester; EMT; Epithelial-mesenchymal transition; ER; Estrogen receptor;